Patents

Skin Treatments Patented by Topix Pharmaceuticals

US Patent 12,016,939 B2 contains retinol and an activation solvent.

Author Image

By: Christine Esposito

Editor-in-Chief

US Patent No. 12,016,939 B2 (Steven M. Hernandez), Topix Pharamceuticals, North Amityville, NY, patented a method for therapeutic treatment of a dermatological condition. It entails topically applying to skin a formulation comprised of a skin treatment active agent comprising retinol and an activation solvent system comprising isopentyldiol, ethoxydiglycol, dimethyl isosorbide, and a non-ionic surfactant. The topical formulation further comprises retinol, ethoxydiglycol, isopentyldiol, dimethyli...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters